Find public news by keyword, exact ticker, category and date.
Open a ticker page for its news coverage. The news search below stays a text search.
2 results loaded, newest first. End of these results. The latest changes are still being indexed. Try again shortly for updated results.
Recursion Pharmaceuticals agreed to sell 61,540,000 Class A shares at $3.25 each, expecting about $200 million in gross proceeds before fees. Closing is targeted for Oct. 16, 2026, subject to customary conditions.
Recursion Pharmaceuticals priced an underwritten offering of 61,540,000 shares of Class A common stock at $3.25 per share. Expected gross proceeds total approximately $200 million before underwriting discounts, commissions and offering expenses; all shares will be sold by Recursion. The offering is expected to close on